Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
ABM Industries ((ABM - Analyst Report)) is slated to report its third-quarter fiscal 2012 results after the closing bell on September 5. The Zacks Consensus Estimate for the quarter is 42 cents per share, representing an estimated year-over-year decline of 17.25%. Revenues, as per the Zacks Consensus Estimate, are $1.09 billion.
Second Quarter Synopsis
The company, in second-quarter fiscal 2012, reported adjusted earnings of 30 cents per share, in line with the Zacks Consensus Estimate and above the year-ago earnings of 28 cents.
Total revenues were flat year over year at $1.06 billion, missing the Zacks Consensus Estimate of $1.09 billion. Top-line growth was negatively affected by delayed start of new contracts along with a declining contribution from government business.
Estimate Revision Trend
Agreement
Out of the 5 analysts covering the stock, none have revised their estimates for the third quarter in either direction over the last 7 and 30 days. A similar trend applies for fiscal 2012.
Magnitude
The Zacks Consensus Estimates remained the same for both the third quarter and fiscal 2012 over the last 7 and 30 days.
Earnings Surprise History
With respect to earnings surprises, ABM Industries' has topped the Zacks Consensus Estimate in two of the trailing four quarters while it met the forecast in other two quarters. The company delivered an average positive earnings surprise of 5.65% over the preceding four quarters, implying that it has beaten the Zacks Consensus Estimate by that measure.
Our Take
ABM Industries' has been experiencing a positive momentum in its Facility Solutions division, especially in the energy sector. The company is now focusing on expanding its efficiency and depth of operations in the Building and Energy Services Unit, driven by soaring client demand and new businesses.
However, accounts receivable make up approximately one-third of ABM Industries' balance sheet. Deterioration in economic conditions could have an adverse impact on ABM Industries’ ability to collect accounts due from its customers, which may weigh on the company’s financial results.
ABM Industries' retains a short-term Zacks #3 Rank (Hold). We have a long-term Neutral recommendation on the stock.
Get the full Analyst Report on ABM - FREE